Clik here to view.
Hill-Rom to pay $330m for Mortara Instrument
Hill-Rom (NYSE:HRC) said today that it agreed to put up $300 million for Mortara Instrument and its line of diagnostic cardiology and patient monitoring devices, not including a $40 million “tax...
View ArticleClik here to view.
Lessons Learned Building Acclarent from Scratch: Interview with Bill Facteau,...
Bill Facteau, President and CEO of Earlens Welcome to the Medsider interview series, a regular feature at MassDevice. All interviews are conducted by Scott Nelson, Founder of Medsider and Group...
View ArticleClik here to view.
Claret Medical wins a date with the FDA for Sentinel TAVR device
An FDA advisory panel is slated to review next month the Sentinel embolic protection device made by Claret Medical, following the company’s bid for de novo clearance last fall. The federal watchdog’s...
View ArticleClik here to view.
Intersect ENT shares jump on Q4 prelims
Intersect ENT (NSDQ:XENT) shares jumped yesterday 11% to reach a peak of $13.20 apiece after the company released its preliminary financial results for the 4th quarter, narrowly beating analysts’...
View ArticleClik here to view.
DexCom gains on Q4 prelims
DexCom Inc. (NSDQ:DXCM) posted its preliminary financial results for the 4th quarter, meeting analysts’ expectations on Wall Street and sending its shares upwards. The San Diego, Calif.-based company...
View ArticleClik here to view.
Neurosurgeon gets 20 years in unneeded spinal surgery fraud scheme
A neurosurgeon in Michigan this week was sentenced to nearly 20 years in prison after pleading guilty to a $2.8 million health care fraud scheme in which he performed unnecessary invasive spinal...
View ArticleClik here to view.
Boston Scientific finds ‘fix’ for Lotus Edge heart valve, preps for May PMA...
Boston Scientific (NYSE:BSX) has reportedly found a fix for its Lotus Edge heart valve after the company paused implantations of the device in October last year. The Marlborough, Mass.-based company...
View ArticleClik here to view.
CytoSorbents shares lift on Q4 prelims
CytoSorbents Corp. (NSDQ:CTSO) posted its preliminary financial results for the 4th quarter, meeting analysts’ expectations on Wall Street. The Monmouth Junction, N.C.-based company said it expects a...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for January 10, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Medtronic updates 2017 guidance
Medtronic (NYSE:MDT) today saw shares rise slightly as it released updates to its full year and 2nd half 2017 guidance, staying mostly in line with previous guidance. The Fridley, Minn.-based company...
View ArticleClik here to view.
J&J to publish list of average drug price increases
Johnson & Johnson (NYSE:JNJ) is reportedly issuing a report next month that will detail how much it has raised the list prices for its prescription drugs. The J&J report will describe average...
View ArticleClik here to view.
Medtronic, J&J and Stryker best places for medtech sales rep jobs
Medtronic, Johnson & Johnson and Stryker remain at the top of the list of best places to work in medical device sales, according to a MedReps.com survey of medical sales representatives. The survey...
View ArticleClik here to view.
Varian Medical details Varex Imaging components spinout
Varian Medical (NYSE:VAR) said today that its board of directors approved the $200 million spin-out of the stand-alone Varex imaging components business and released more information on the...
View ArticleClik here to view.
Zimmer Biomet lifts on Q4 prelims
Zimmer Biomet (NYSE:ZBH) released Street-topping preliminary earnings numbers for its 4th quarter and full year 2016, sending shares up over 6%. Warsaw, Ind.-based Zimmer Biomet said it expects to...
View ArticleClik here to view.
ALung Technologies brings in $2.6m
Artificial lung-like device developer ALung Technologies has raised $2.6 million in a new round of financing, according to an SEC filing posted this week. Pittsburgh-based ALung’s Hemolung device is...
View ArticleClik here to view.
Robotic med device start-up Medineering Series A led by Brainlab
German robotic surgical start-up Medineering said today it closed a Series A funding round led by its new strategic partner Brainlab. Through the partnership, Brainlab will aid Medineering as it works...
View ArticleClik here to view.
Nico launches trial for brain surgery shunt
Nico Corp said today it enrolled the 1st patient in the Enrich clinical trial which aims to explore the use of its BrainPath Approach for treating intracerebral hemorrhages. The trial will examine the...
View ArticleClik here to view.
Transition to the new European Medical Device regulations: Risks for the...
By Stewart Eisenhart, Emergo Group In their effort to safeguard the quality of Notified Bodies (NBs), European authorities are increasing scrutiny. This has resulted in a reduction of the number of NBs...
View ArticleClik here to view.
Stryker gains on Q4 prelims
Stryker (NYSE:SYK) shares are up after the orthopedics and hospital equipment giant posted preliminary financial results for the 4th quarter that narrowly beat the consensus forecast on Wall Street....
View ArticleClik here to view.
FDA clears next-gen Sonablate prostate device from SonaCare
SonaCare Medical said today that it won 510(k) approval from the FDA for the latest version of its high intensity focused ultrasound prostate tissue ablation device. The Sonablate device was the 1st of...
View Article